SEBI Proposes Easing of Investments by Indian Mutual Funds in Foreign Funds
SEBI Report; Dated: 17.05.2024 SEBI … Continue reading “SEBI Proposes Easing of Investments by Indian Mutual Funds in Foreign Funds”
Blog
SEBI Redefines the Applicability of LODR Norms | Specifies Period for Calculating Average Market Capitalization
Notification No. SEBI/LAD-NRO/GN/2024/177; Dated: 17.05.2024 … Continue reading “SEBI Redefines the Applicability of LODR Norms | Specifies Period for Calculating Average Market Capitalization”
Target-co.’s Share Price Impact From Material Price Movements Can Be Excluded When Determining Offer Price | SEBI
Notification No. SEBI/LAD-NRO/GN/2024/179; Dated: 17.05.2024 … Continue reading “Target-co.’s Share Price Impact From Material Price Movements Can Be Excluded When Determining Offer Price | SEBI”
Unverified Media Reports to Be Excluded From Purview of ‘Generally Available Information’ Under Insider Norms | SEBI
Notification No. SEBI/LAD-NRO/GN/2024/181; Dated: 17.05.2024 … Continue reading “Unverified Media Reports to Be Excluded From Purview of ‘Generally Available Information’ Under Insider Norms | SEBI”
SEBI Allows Non-individual Public Shareholders Holding 5% of Post-issue Capital to Meet Min. Promoters’ Contribution
Notification No. SEBI/LAD-NRO/GN/2024/178; Dated: 17.05.2024 … Continue reading “SEBI Allows Non-individual Public Shareholders Holding 5% of Post-issue Capital to Meet Min. Promoters’ Contribution”
Co.’s Share Price Impact Due to Material Price Movement Excluded From Volume-Weighted Average Price Under Buyback Norms | SEBI
Notification No. SEBI/LAD-NRO/GN/2024/180; Dated: 17.05.2024 … Continue reading “Co.’s Share Price Impact Due to Material Price Movement Excluded From Volume-Weighted Average Price Under Buyback Norms | SEBI”
[Analysis] Advocates’ Accountability vs. Consumer Rights | M. Mathias v. D. K. Gandhi PS National Institute of Communicable Diseases
Can you take legal action … Continue reading “[Analysis] Advocates’ Accountability vs. Consumer Rights | M. Mathias v. D. K. Gandhi PS National Institute of Communicable Diseases”
CA | CS | CMA
